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Abstract
The often touted advantages of MR guidance remain largely unrealized for cardiovascular
interventional procedures in patients. Many procedures have been simulated in animal models. We
argue these opportunities for clinical interventional MR will be met in the near future. This paper
reviews technical and clinical considerations and offers advice on how to implement a clinical-grade
interventional cardiovascular MR (iCMR) laboratory. We caution that this reflects our personal
view of the "state of the art."
Background
Why interventional CMR?
Surgical procedures afford direct exposure for visualization
(optical imaging) of target tissue and access for mechanical
intervention. This permits instant recognition of impor-
tant complications like bleeding to allow immediate cor-
rection during the procedure. Unfortunately surgical
exposure is morbid, meaning it produces physiological
and geometric derangement, discomfort, immobilization,
and risk.
Catheter-based (i.e. endovascular) approaches have revo-
lutionized the treatment of cardiovascular disease. X-ray
fluoroscopy guides a wide range of minimally invasive
procedures, including treatment of obstructive coronary
artery disease, peripheral artery atherosclerosis and aneu-
rysm, and structural or congenital heart disease. X-ray
infrastructure is widely deployed, and versatile catheter
devices are commercially available. X-ray fluoroscopy
depicts soft tissue structures poorly and requires skilled
operators to make assumptions about anatomic land-
marks that may be inaccurate. X-ray exposes patient and
operator to ionizing radiation that increases with proce-
dure complexity, and significant career musculoskeletal
injury to operators forced to wear protective lead aprons.
While the actual risk of radiation injury remains contro-
versial, even low-level exposure to ionizing radiation is
thought to contribute to the long-term risk of malignancy
[1,2]. Children are considered more sensitive to radiation
and may live longer to experience radiation toxicity. Chil-
dren requiring catheterization for congenital heart disease
often require multiple procedures over time. Chromo-
somal damage was evident in the peripheral blood of chil-
dren exposed to catheterization-related radiation [3].
The great promise of iCMR is to provide some of the soft-
tissue visualization afforded by direct surgical exposure
with the reduced morbidity of X-ray catheter procedures.
MR is attractive in the ability to display different blood
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and tissue contrasts, motion, flow, etc without ionizing
radiation. This comes at the expense of increased opera-
tional complexity, reduced temporal and spatial resolu-
tion, and limited availability of catheter devices that are
safe and visible under MR. For certain applications, these
difficulties might be justified. Complex and prolonged
procedures in children who are especially sensitive to
long-term toxicity from radiation exposure, is one exam-
ple. New interventional alternatives to conventional open
surgery are another. Improved recognition and response
to iatrogenic injury, such as perforation, is yet another.
Real-time interactive MR
Diagnostic MR utilizes longer image acquisition (for
example ECG-gated segmented MR) and off-line recon-
struction for higher image quality. Real-time MR com-
bines acquisition, reconstruction, and display to provide
operators images with low latency, empirically less than
250 ms compared with 100 ms for X-ray fluoroscopy. X-
ray fluoroscopy produces 15 relatively sparse frames per
second with a pixel matrix of 1024 × 1024 and a field of
view of 8–40 cm. In real-time MR, the imaging matrix
(and thus spatial resolution) is reduced in size to support
an imaging speed between 5 and 10 frames per second [4].
Even at a reduced pixel imaging matrix such as 192 × 128
at 8 acquired frames per second, real-time MR is compara-
bly information-rich. Most modern real-time MR imple-
mentations employ balanced steady state free precession
(SSFP, also known as TrueFISP, bFFE, or FIESTA) tech-
niques because of efficient use of magnetization, high
SNR, and short repetition times. Fast spin echo techniques
produce excellent image quality, but are less attractive for
real-time applications because of higher specific absorp-
tion rates (SAR) of heat from radiofrequency energy and
longer acquisition times. In addition to conventional rec-
tilinear sampling strategies, spiral and radial trajectories
are also well-suited for real-time imaging [5,6].
Image acquisition speeds may be accelerated through par-
tial and/or parallel acquisition schemes. Partial acquisi-
tions asymmetrically skip some data acquisition in either
the frequency (partial echo) or phase encoding direction,
and the missing data is synthesized with techniques such
as homodyne reconstruction [7] or projection onto con-
vex sets [8]. Parallel acquisition schemes acquire under-
sampled datasets by skipping some phase-encoding lines,
and exploit the sensitivity profiles of multiple coils to
reconstruct the missing data. The two most commonly
used algorithms for parallel image reconstruction are
SENSE [9,10] and GRAPPA [11]; with specialized coil
arrays and sufficient computational horsepower, four-fold
acceleration rates are typically achieved [12] (vide infra).
The computational demands on image reconstruction are
greatly increased, but real-time interactive imaging with
TSENSE has been demonstrated using computers with
multiple CPUs [13].
The major commercial MR systems provide real-time SSFP
capability with interactive graphic slice prescription dur-
ing continuous scanning. Some interventional implemen-
tations use separate external reconstruction computer
systems operating in parallel, having bidirectional links
for scan control, providing rapid image reconstruction.
Guttman, McVeigh, and Ozturk developed such a compre-
hensive interactive real-time MR reconstruction system for
interventional applications at NIH [14]. This system fea-
tures real-time imaging of multiple slices and displays
these slices in their relative three-dimensional position.
Perhaps most important is the ability independently to
process and highlight signals from individual receiver
channels, especially those attached to intravascular
devices [15]. Highlighted devices are then easily distin-
guished from each other and surrounding tissue, provid-
ing high user confidence in iCMR guidance. Other
interactive features we have found useful include device-
only projection imaging, electrocardiographic gating to
suspend cardiac motion and saturation pre-pulses to
enhance the appearance of gadolinium during injections
into arteries, devices, or myocardium having late gadolin-
ium enhancement. Image-acceleration is controlled inter-
actively. It has proven useful to apply subtraction masks
for interactive real-time digital-subtraction MR angiogra-
phy [16].
Santos and colleagues at Stanford University have devel-
oped a real-time MR system (RTHawk), which allows
dynamic switching between pulse sequences and recon-
struction algorithms [17]. This system enables the user to
rapidly switch between low spatial resolution localizers
and high spatial resolution images, analogous to "fluoros-
copy" and "cineangiography" X-ray modes. The system
also accommodates active device tracking by interspersing
3 orthogonal projections for device localization and real-
time overlay of the device position on anatomical images.
Device-scanner interaction also can be automated. For
example, the group at Case Western Reserve University
automatically increases temporal resolution and field of
view when rapid device motion is detected, then increases
spatial resolution and decreases field of view when device
motion is low [18]. The effect is to "zoom in" and slow
down for more accurate imaging during fine device posi-
tioning [18].
Our investigational interventional procedures are guided
by multiple slices acquired and displayed in rapid succes-
sion. A three-dimensional volume-rendering of the slices
conveys their relative positions. Updates of individual
slices can be paused or reactivated as needed during a pro-Journal of Cardiovascular Magnetic Resonance 2008, 10:62 http://www.jcmr-online.com/content/10/1/62
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cedure. This type of display can further be enhanced by
permitting the user interactively to apply point markers
on important anatomic features or targets, make measure-
ments on-line, and combine with prior roadmap images
to make rapid before-after comparisons.
Many of these concepts have been incorporated into an
"Interactive Front End" system developed by Christine
Lorenz of Siemens Medical Systems and available for
investigational use [19].
iCMR operators have two general imaging approaches.
For some applications, imaging is directed at target
pathology, while devices are manipulated in or out of the
desired target slice. Alternatively, the real-time imaging
slice can automatically track catheter movements and alter
the slice prescription so as always to keep the desired cath-
eter device in view, while changing the view of the neigh-
boring anatomy. Ideally, both imaging techniques should
be available to the operator. We have found a "projection-
mode" feature useful during catheter manipulations
within target slices. When parts of catheter devices move
outside of a typical thin-slice image, they are no longer
visible to the operator. By toggling projection-mode
(which switches to thick-slice or non slice-selective imag-
ing), the catheter can be "found" and manipulated back
into the target slice. Combining an "adaptive" projection
mode (automatically orthogonal to the selected viewing
angle) with multi-slice three-dimensional rendering has
been especially useful (Figure 1).
Outfitting a laboratory to perform interventional CMR 
procedures
This section attempts to answer questions raised during
site visits. Readers are cautioned our recent first-hand
experience is limited to one system vendor.
How do we site the imaging equipment? How do we justify an 
interventional MR system when there are no remunerative iCMR 
procedures?
A lab for investigational interventional procedures should
be configured with emergency bailout procedures in
mind. We recommend interventional CMR laboratories
adjoin conventional X-ray systems. Adjoining X-ray and
MR systems can be configured to operate independently
or together. The only incremental capital outlay required
is for an intermodality patient transport system and for
doors that separate the adjoining labs. Intermodality
transport systems are available from all major system ven-
dors and generally consist of floor-mounted rails or free-
moving trolleys conveying a multimodality patient cradle
or shell. Doors can maintain the radiofrequency shield of
the MR lab and can contain lead if separating distance
doesn't provide enough radiation protection. Doors can
be motorized or manually-operated. One vendor (IMRIS)
mounts an MR system on ceiling tracks for movement
between multiple operating rooms or interventional
suites while the patient table remains stationary. A com-
mon control room for the adjoining MR and X-ray can
reduce additional costs. Video systems can substitute for
radiofrequency-shielded windows into the MR lab (Figure
2).
This is an example of "adaptive" projection navigation Figure 1
This is an example of "adaptive" projection navigation. Two dimensional slices are volume-rendered to show their 
three-dimensional position. In addition, the active catheter device is shown in superimposed projection-mode. The viewing 
angle of the two-dimensional slices can interactively be changed [A-C], but in this mode the projection angle is always perpen-
dicular to the selected viewing angle. In this example, an active myocardial injection catheter is navigated toward an infarct bor-
der. The catheter contains two receiver coils: a small coil at the tip (red) and a loopless antenna along the shaft (green). A 
yellow dot is applied by the operator to mark the tissue target. The volume rendering is rotated manually during the proce-
dure to view the device trajectory from different angles, conveying three-dimensional information [14]. In A and B, the cathe-
ter tip is outside the imaging plane; in C the catheter tip is in-plane and coincides with the selected target.
ABCJournal of Cardiovascular Magnetic Resonance 2008, 10:62 http://www.jcmr-online.com/content/10/1/62
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Conversely, co-localizing X-ray and MR systems within a
single radiofrequency shield does not appear a cost-effec-
tive solution, because the systems cannot be used inde-
pendently. Indeed X-ray systems generally need to power-
down because they generate radiofrequency noise during
MR. The "cold" start-up time for X-ray systems can be
onerous if emergency bailout imaging is required. Mobile
C-arm X-ray systems generally provide inferior imaging
and gantry positioning and are unattractive for high-risk
cardiovascular interventional procedures.
All intermodality transfers should be smooth, rapid, and
convenient. Configurations that require complex rotation
of the patient table in order to move between X-ray and
MR are none of these. Indeed, patients often are attached
to bulky appliances such as pumps and ventilators that
might also need to travel as the patient table is rotated. For
dual-use suites, siting plans should provide separate
patient entry and egress for the X-ray system that is outside
the high (5 gauss) magnetic field, especially when many
patients undergoing conventional catheterization may
have "MR unsafe" or "MR conditional" cardiovascular
implants [20].
Interventional procedures have been conducted in MR
systems ranging from low-field (<1.0 T) open magnets to
long bore high-field (3.0 T) systems. While open systems
allow easier patient access, they tend to have inferior
image quality. High-performance SSFP is available in 1.5
T systems and becomes more challenging at higher fields
because of inhomogeneity of the main field and higher
SAR. Shorter- and wider-bore systems are available at 1.5
T and 3.0 T that enhance operator access to the patient,
but require compromises in main field homogeneity and
head-to-foot field of view.
Hemodynamic monitoring and recording
During interventional procedures patients receive medica-
tions that may depress spontaneous breathing, or they
may suffer sudden hemodynamic deterioration. These
A combined X-ray and MRI interventional suite Figure 2
A combined X-ray and MRI interventional suite. The two systems can be used independently or together, when the 
radiofrequency-shielded and leaded doors are retracted. Patients can be transferred between labs on a cradle that slides along 
a motorized table. Each room can display real-time images, instantaneous hemodynamics, and imaging control to the operator. 
Both share a common control room for support staff [45].Journal of Cardiovascular Magnetic Resonance 2008, 10:62 http://www.jcmr-online.com/content/10/1/62
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procedures therefore require a higher level of human and
technical vigilance than does diagnostic MR. Commer-
cially available MR hemodynamic monitoring solutions
may not be adequate.
Comfort and respiratory effort are best monitored by
direct visualization. If this is not feasible, video and light-
ing equipment should be installed inside and outside the
magnet bore to permit the staff to assess patient respira-
tory efforts, comfort, and even skin color as an index of
perfusion or autonomic state.
Hemodynamic "monitoring" systems are distinguished
from "recording" systems. The former is for keeping
patients safe, the latter for obtaining high-fidelity meas-
urements suitable for cardiovascular diagnosis and treat-
ment. Monitoring systems typically have slower sampling
rates, fewer available channels, and are considered unsuit-
able for heart catheterization. Commercially available
monitoring systems often can output analog signals for
computerized display, albeit with low-fidelity. There are
no commercially available clinical hemodynamic record-
ing systems for MR, although non-clinical systems are
readily adapted (e.g. Powerlab, ADInstruments Inc) for
investigational use. We use the same disposable pressure
transducers for both X-ray and MR. We believe interven-
tional labs should have the capability to monitor and
record at least two instantaneous blood pressure channels
(for gradient determination) as well as one intermittent
non-invasive blood pressure recording device.
During conventional X-ray procedures, electrocardio-
graphic (ECG) signals are monitored or recorded from
four surface electrodes on the limbs and between one and
six on the chest. These are connected to long conductive
transmission lines that are prone to heating and therefore
unsuitable for use in MR. Clinical MR safe ECG electrode
leads are typically short, shielded, fewer, and often wire-
less. Even if MR cardiac gating is not planned, the skin sur-
face should be prepared for good contact with ECG
electrodes for cardiac monitoring. Most labs use two sets
of ECG electrode leads, one for use in MR and a neighbor-
ing set for use in X-ray. Dual-use ECG transmission lines
are not commercially available. Laboratories should plan
for the inconvenience and hazard of disconnecting and
reconnecting ECG leads before each intermodality patient
transfer, until a commercial solution is available. Conven-
tional X-ray electrodes must be removed prior to MR.
Electrocardiographic waveforms are altered when the
patient is in the magnet and further during scanning. Mag-
netic gradients introduce ECG noise that can be filtered by
commercial equipment. Electrocardiographic repolariza-
tion patterns (the "ST-segment"), which under normal
conditions can be monitored for evidence of myocardial
ischemia or injury, are irrevocably distorted by the mag-
neto-hydrodynamic effect of cardiac and aortic flow of
blood ions. Any procedure that might inadvertently injure
myocardium or induce direct or paradoxical coronary
embolization of atheromata, thrombi, or air should be
conducted only with a monitoring plan that includes a
surrogate for ECG repolarization. This might include
intermittent real-time surveillance of myocardial motion,
instantaneous blood pressure monitoring, or more
sophisticated approaches.
Numerous cables and devices are connected to patients
during interventional procedures (see below, Inputs and
outputs for patient monitoring and care during interven-
tional CMR procedures). These should be positioned to
permit rapid entry and exit from the magnet bore toward
X-ray bailout. Our preference is that cables, tubes, and
interventional devices only enter the magnet bore from
the side closest to the X-ray. We also believe the operator
must have direct access to (in order to secure) intravascu-
lar devices throughout intermodality transfer. For trans-
femoral procedures this means the X-ray table is
positioned head-to-foot with regard to the MR, and the
patient enters the magnet bore head-first. Operators
should verify that conductive cables are kept away from
the wall of the magnet bore and are not coiled, since these
predispose to heating during MR.
Inputs and outputs for patient monitoring and care during 
interventional CMR procedures
￿ Line-of-site for visual assessment of breathing and com-
fort, or video surrogate
￿ Electrocardiographic electrodes, leads/cables for X-ray
(and for MR, if different)
￿ Invasive blood pressure transducers, at least two chan-
nels
￿ Noninvasive blood pressure cuff (oscillometric sphyg-
momanometer)
￿ Hemoglobin saturation ("pulse oximetry")
￿ Intravenous lines and MR-compatible intravenous
pumps, configured to allow free movement of patient
between MR bore and X-ray system
￿ Accessible port for manual infusion of additional medi-
cations
￿ Audio communications system
￿ Video entertainment system, if implementedJournal of Cardiovascular Magnetic Resonance 2008, 10:62 http://www.jcmr-online.com/content/10/1/62
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￿ Patient-controlled alarm
￿ Surface coils, transmission lines, and connectors
￿ Interventional coil transmission lines and connectors
￿ Clips and bags to assure sterility
￿ Interventional catheterization manifold, typically
including a blood pressure transducer, multiple stop-
cocks, a controlled volume syringe, saline flush, contrast
flush, and waste receptacle
￿ Oxygen tubing, or anesthesia tubing and anesthesia gas
monitor
￿ Temperature sensor
iCMR laboratories should establish a system for safe
resuscitation and defibrillation. Defibrillation equipment
is not MR safe and can become a projectile inside the high
magnetic field. Moreover, defibrillation currents inside
the magnetic field generate enough force to knock over
the operator. In our laboratories, the X-ray lab serves as
the evacuation destination for cardiovascular emergen-
cies.
For video display, LCD projectors are a cost-effective solu-
tion. Commercial projectors function well even when
incorporated in radiofrequency shields including copper-
screens across the lens. Some commercial LCD projectors
function well without modification or shielding. We pre-
fer rear-screen projectors, which we find to perform well if
they are greater than 2000 ANSI lumens. Unshielded LCD
projectors also could transmit through properly situated
waveguides. In addition, shielded and boom-mounted
LCD displays are commercially available.
Shielded keyboard and mouse solutions are available
from commercial vendors, but ordinary USB or Bluetooth
keyboards and mice suffice if filtered through a penetra-
tion panel. Some laboratories also use foot-pedal controls
to start and stop MR scanning, or to manipulate slice posi-
tion.
Other siting considerations bear mention. Because iCMR
remains investigational, the lab should be configured
with ample space for multiple penetration panels near the
control console, alongside the in-lab monitoring and dis-
play equipment. This enables new devices and control ele-
ments to be introduced without disturbing the
radiofrequency shield. Multiple waveguides should be
anticipated near the patient monitoring equipment, for
non-conductive patient care equipment such as fiberoptic
transmission lines. Other waveguides might be installed
to facilitate LCD projectors outside the RF cage (see
above). Inside the radiofrequency cage, multiple outlets
should be installed for anesthesia gases on both sides of
the magnet bore, including at a minimum medical air,
oxygen, suction, and anesthesia exhaust. Multiple
shielded AC electrical outlets should be installed, includ-
ing connection to "emergency clinical power." There
should be at least one sink inside the lab to dispose of bio-
logical fluids. Conceivably this sink can be prepared for
surgical scrubbing.
Because equipment from the adjoining X-ray lab can be
rolled into the MR lab, special training and operating pro-
cedures need to be established. Dual-use procedure tables
and "Mayo-stands" should be MR safe. All equipment in
the entire suite should clearly be labeled "MR-safe" or
"MR-unsafe." "Unsafe" equipment that must be used in or
near the MR system should be hard-tethered to the floors
and walls to keep them away from the high fields (we use
plastic chain-link tethers). Some laboratories draw mag-
netic field lines on the floor. To avoid inadvertent projec-
tiles from staff pockets, some laboratories require pocket-
less surgical scrub costumes.
Laboratories with double-door "RF lock" systems permit
staff to enter and exit the scanner room without interrupt-
ing the RF shield. Other laboratories, including ours, tol-
erate the transient RF noise generated during real-time
scanning as doors open and close.
MR gradients induce sufficient acoustic noise to interfere
with voice communications, even using newer shielded
gradient systems. Commercial systems are available that
suppress or subtract acoustic noise; permit "open-micro-
phone" communications among sterile staff without
hands available for "push-to-talk" controls; and include
multiple channels for parallel staff-patient and staff-staff
communications. These may have pneumatic or fiberop-
tic transmission lines and, in the future, may have wireless
capability. Washable wall and ceiling tiles with acoustic
damping properties enhance hygiene and suppress acous-
tic noise.
Do animals belong in human iCMR suites?
iCMR systems require in vivo testing during investigational
development, which requires either animal or human
subjects. We believe rehearsal procedures and experi-
ments in animals significantly enhance safety in patients.
Many medical centers restrict or prohibit animal experi-
mentation on clinical equipment largely on aesthetic or
public relations grounds. We assert that human pathogens
and blood products pose an immediate hazard of patient-
to-patient infection yet animal tissue and dander are com-
monly ingested and pose little appreciable risk. The risk of
allergic sensitization is mitigated by aggressive "operating-Journal of Cardiovascular Magnetic Resonance 2008, 10:62 http://www.jcmr-online.com/content/10/1/62
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room" cleaning procedures after every animal experiment
(and after every human procedure). In our dual-use facil-
ity, we have conducted hundreds of animal and human
invasive and interventional procedures over seven years
with no evident human infective or allergic complica-
tions.
Our MR and X-ray rooms are each equipped with separate
air handling systems. All input air may be filtered (high
efficiency particulate air, HEPA), all output air is
exhausted from the building without recirculation ("sin-
gle-pass air"), and the suite has a slight (negative) pressure
difference compared with neighboring surgical suites, to
contain animal odors.
Procedures for animal transportation were negotiated
among interested parties in the hospital. Large mammals
enter the building only under general anesthesia; are
transported within the hospital on gurneys under blan-
kets to disguise the contents; and are transported only
along designated pathways and elevators to minimize
contact with patients and lay visitors. All disposable
equipment and medications intended for animal use are
sequestered in a locked storage area during human proce-
dures.
Separate equipment such as mechanical ventilators, defi-
brillators, intravenous pumps, and transport cradles are
dedicated for animal use. Equipment connected by cable,
such as hemodynamic recording, intravascular ultra-
sound, are permitted for dual use. Disposable plastic bags
isolate equipment such as MR surface coils when used for
animal experiments.
Conspicuous and safe catheter devices
iCMR would probably already be in widespread use if
conspicuous and safe clinical-grade catheters were readily
available. The gap reflects the complexity of such devices
and limited perceived return on industry investment.
Interventional catheter devices for X-ray procedures gener-
ally incorporate ferrous materials to impart mechanical
characteristics (such as ability to transmit torque, to navi-
gate tortuous structures, and to support insertion of less-
flexible devices such as stents, endografts, and closure
devices). Some, like widely-employed 316L stainless steel,
are not significantly attracted by magnetic fields, but all
create large imaging artifacts. As a result, most commercial
braided diagnostic and guiding catheters, balloon-
expandable stents, guidewires, and device delivery sys-
tems are not suitable for MR. Replacing the ferrous mate-
rials with "MR safe" materials such as polyester braiding
usually renders the devices MR-inconspicuous. Other
metals are better suited, including nitinol, many nickel-
cobalt-chromium alloys (MP35N, L605, etc.), copper,
gold, tungsten, titanium, and platinum, in that they create
comparably minor magnetic susceptibility artifacts. Not
all of these materials are biocompatible.
Conventional catheter components have intrinsic imag-
ing "signatures" based on their X-ray attenuation that
indicate catheter or guidewire tips, balloon inflation bor-
ders, transition zones where devices become stiff, second-
ary angulations where counterforce is applied, stent
mount points, endograft sleeve components, docking
locations, fixation pins, etc. These component imaging
signatures are important to guide operators during inter-
ventional procedures, and replicating them under MR is a
challenge. In case of device malfunction, even the distal
shaft of a device may need to be visualized. Therefore the
entire length of catheter devices must generally be visible
for invasive procedures, not just the distal tip.
Interventional MR catheter devices (Figure 3) are typically
classified as "passive" or "active" depending on whether
they are visualized based on intrinsic materials properties
(passive) or based on signals from embedded receiver
coils and electronics (active). Hybrids and combinations
are also attractive options. The different approaches are
summarized in Table 1.
As mentioned above, because most iCMR procedures use
two-dimensional thin slices, parts of a flexible catheter
may move outside the selected imaging slice. This is espe-
cially important with regards to the tip of a catheter. In
this way iCMR and two-dimensional ultrasound-guided
procedures differ substantially from projection X-ray
fluoroscopy-guided procedures. In iCMR we compensate
using interactive projection modes.
Passive catheters
Passive catheters are attractive in their simplicity but suffer
from low contrast-to-noise ratios and non-specificity of
image appearance. Passive devices are visible because of
their intrinsic material properties. These may cause nega-
tive contrast through local distortions of the magnetic
field (black spots) or positive contrast through enhanced
local signal (bright spots). Black spots in an image can
reflect many causes, and those created by passive devices
(signal voids from intentional magnetic susceptibility
artifacts) have low contrast compared with tissue. Black
spots also suffer partial volume averaging artifacts more
readily than do sources of intense signal (such as local
receiver coils). Non-specificity refers to the inability to dis-
tinguish unique catheter image "signatures" from imaging
artifacts. Vascular MR images have many long black lines
that can be confused with black lines created by in-plane
imaging of (susceptibility-based) passive catheters. This is
not acceptable during catheter navigation near vital struc-
tures for interventional procedures. Susceptibility-Journal of Cardiovascular Magnetic Resonance 2008, 10:62 http://www.jcmr-online.com/content/10/1/62
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induced black spots usually are much larger than the
markers they represent. This "blooming" enhances visibil-
ity at the expense of extinguishing signal from surround-
ing target tissue.
Some groups use large devices, such as CO2-filled bal-
loons [21], to displace water in order to make catheters
conspicuous, to exploit their bloodstream flotation, and
to minimize blooming. Others fill balloons with T2*-
shortening agents to make them conspicuous and to dis-
tinguish them from blood during bright-blood imaging
[22].
Several teams have developed off-resonance imaging
sequences intended to make susceptibility marker cathe-
ters appear bright [23-25]. These can be safe and effective,
but detract from tissue imaging and may depend on
marker orientation with respect to the static magnetic
field.
Unal and colleagues [26] and others have reported passive
catheters coated or filled [27] with T1-shortening hydro-
gels or contrast agents, but follow-up reports have been
limited. Technical challenges include accessibility of
excited water spins to the contrast agent, enhanced T2*-
effects of solid-phase or surface-affixed contrast agents,
leaching, and replacing usable catheter volume (that oth-
erwise could deliver large interventional devices) with
contrast agents.
Given these limitations, we find the use of passive catheter
devices alone to be generally inferior for interventional
procedures.
Active catheter devices
Active devices have electronic components incorporated
into their mechanical design. "Active-tracking" catheters
incorporate receiver coils that are used with brief non-
imaging pulse sequences to determine their position in
space [28-35]. A common implementation is to interleave
brief tracking pulses sequences with imaging pulse
sequences, compute the coil coordinates, and to display
position markers on the images to represent coil position.
Alternatively, the position of active-tracking markers can
be superimposed on prior or intermittently updated MR
images [36].
One early active-tracking design induced local field inho-
mogeneities using direct current at the catheter tip
[37,38]. This uses a blinking mode to impart specificity
but suffers the disadvantages of both active and passive
designs. A more recent design opposes solenoids for track-
ing as well as for high-sensitivity trans-axial imaging [39].
In addition to imaging and tracking, the device mounted
coils can be used to estimate flow in real-time [40].
Robin Medical is commercializing a magnetometer
approach for catheter tracking [41]. Position is deter-
mined based on timing of detected magnetic field gradi-
ents during imaging. Clinical products are available for
neurosurgery, and investigational products are under
development for cardiac electrophysiology MR catheters
[41].
"Active-imaging" (also called "active-profiling") catheters
incorporate receiver coils that contribute to the creation of
MR images, and they are tracked based on their position
within images. The catheter coils can be attached to sepa-
rate receiver channels for reconstruction. Colorized dis-
play of catheter channels is a useful way to impart
specificity to catheter-related signal [15,42,43]. Typically,
active-imaging catheters are displayed with nebulous bor-
MRI catheter designs Figure 3
MRI catheter designs. (A) Conventional X-ray catheters 
are maneuverable in part because they contain steel braiding 
that distorts MR images. (B) With steel braiding removed, 
the same "passive" catheter is inconspicuous. (C) An "active" 
version of the same catheter in (B) has a loopless-design MRI 
receiver coil along its length, and another loopless-design 
guidewire receiver coil inside. Both are conspicuous along 
their shaft or profile. (D) A clinical grade balloon-tipped cath-
eter can be filled with CO2 gas and appears as a black spot 
(dashed white arrow). This catheter has been manipulated 
from the femoral vein to the right ventricle in a patient 
(courtesy Reza Razavi, King's College London). (E) "Active 
tracking" in a porcine right ventricle (courtesy Steffen Weiss, 
Phillips Research Europe). A computer-synthesized cross-
hair indicates the catheter position on an interleaved image. 
(F) Multiple channel "active imaging" catheter prototype 
where the shaft is seen in blue, proximal and distal tip micro-
coil markers are seen in green, and the catheter bend is seen 
as an orange signal.
d
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ders, unlike image depiction of X-ray catheters with sharp
borders.
Simple active-imaging guidewires with a "loopless"
design and 0.030" diameter (Surgi-Vision) have been
tested clinically for catheter tracking or invasive imaging
[44-46], and have even been reduced to 0.014" diameter
[47]. These suffer limited antenna sensitivity near the tip,
which reduces their clinical utility for navigating complex
lesions and structures. More complex active-imaging
guidewires with enhanced mechanical performance,
shaft, and tip visibility, are under clinical development.
Active catheter devices usually operate in receive-only
mode, but transmission-mode can dramatically reduce
the local power absorption if it is not necessary to view
surface coil images [48,49].
Imaging-active devices appear even brighter when used
with contrast agents inside or alongside them [50], espe-
cially when combined with colorized display. For exam-
ple, angioplasty balloons filled with dilute gadolinium
contrast used together with active guidewires appear
highly conspicuous and, by virtue of color-highlighted
display, specific [51] (Figure 4).
Transmission lines, heating, and solutions
Conductive wires can resonate and heat during radiofre-
quency excitation for MR [52-54], whether part of active
or passive devices. This has proven an important obstacle
in implementing active catheter systems and in engineer-
ing mechanically effective catheters and guidewires. Very
short wires are generally safe; very long wires can be safe
also [55]. Resonating transmission lines also can deliver
electric shock to the patient, especially when contacting
myocardium, unless adequately insulated.
Fiberglass guidewires, doped with dysprosium suscepti-
bility markers, were developed more than a decade ago
[56] to avoid inductive heating, but had inadequate
mechanical performance for human use. A nonconduc-
tive clinical-grade guidewire has been engineered by Bile-
Table 1: A comparison of catheter designs for interventional MRI.
Approach Advantages Disadvantages Examples
Passive catheters, visible based on 
intrinsic materials properties
Simple, inexpensive
Can be used in combination with 
other approaches
Non-specific catheter "signatures"
"Compatible" conductive wires can 
heat
Must not contain ferrous braids
Gadolinium-filled balloon dilatation 
catheters.
Non-braided angiography 
catheters
Polymer guidewires [57]
Active "imaging" catheters, 
incorporating MRI antennae
Highly conspicuous
Catheters can be depicted in color
Versatile imaging approaches 
including projection-mode
Complex, expensive
Conductive wires can heat
Blurry profile compared with X-
ray catheters
Dipole designs have poor distal tip 
visibility
Surgi-Vision Intercept 0.030" dipole 
guidewire coil
Boston Scientific MRI Stilletto 
endomyocardial injection system
Active "tracking" catheters, 
incorporating MRI antennae
Simple, inexpensive
Coils can be tracked without 
imaging, to increase speed, reduce 
heating, reduce acoustic noise
Coils can be used to automate 
scan plane adjustments
No real-time MRI
Catheter locations are computer-
synthesized on image
Conductive wires can heat
MGH/General Electric 
electroanatomic mapping and MRI 
system [36]
Active catheters inducing 
susceptibility artifacts
Simple
Controlled artifacts confer 
specificity
No imaging
Heating of transmission lines when 
employed
Fiberoptic-detuned tracking coil 
[72]
Inductively-coupled devices Requires no physical connection
Reverse polarization mode may 
display unique device signature and 
allow high flip angle
Embeds electronics that might 
interfere with mechanical 
performance (i.e. on stents)
Low flip angle compromises 
imaging
Essen wireless stents [69] and 
catheters [70]
Multispectral devices Non-proton MRI species can be 
displayed in different colors from 
target tissue
Passive imaging that does not 
require transmission lines or 
embedded electronics
Additional hardware required for 
exciting and detecting the 
alternate compounds
Hyperpolarized 13C requires 
constant replenishment using 
specialized generator hardware
13C selective coronary 
arteriography [78]
19F catheter tracking [76]
Magnetically-deflected devices Harness magnetic field to steer or 
even un-tether device
May compromise imaging
May compromise mechanical 
capabilities
Untethered device navigation [75]
Integrated catheter MRI Requires no conventional MRI
Operates inside ordinary X-ray lab
Non-imaging device Topspin intracoronary catheter 
[80].Journal of Cardiovascular Magnetic Resonance 2008, 10:62 http://www.jcmr-online.com/content/10/1/62
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cen's group in Basel [57] out of polyetheretherketone
(PEEK) with improved mechanical performance. An iron-
doped coating creates controlled susceptibility artifacts at
the tip. The Philips Hamburg group describes a manufac-
turing technique called "micro-pultrusion" to create a
non-metallic guidewire that compares favorably with
widely-used clinical nitinol (Glidewire, Terumo)
guidewires [58]. This wire has a short nitinol tip for per-
formance and is doped or coated with iron, barium, and
tungsten for visibility under MR and under X-ray. Because
guidewires are fundamental tools for catheter procedures,
these represent important enabling technologies for clini-
cal interventional MR procedures in spite of the limita-
tions of passive device tracking.
Heating has been attenuated in conductive transmission
lines using coaxial chokes [59] and circuitry to detune or
decouple during RF transmission[60], and by interposing
serial transformers [61,62].
Atalar argues that any device can be safe from heating, as
long as the radiofrequency excitation energy is limited
appropriately [63]. Specific absorption rate (SAR) of radi-
ofrequency energy is related roughly to the square of the
static magnetic field strength, the square of the excitation
flip angle, the square of the distance of conductive device
from the center of the body, and inversely related to repe-
tition time and to radiofrequency pulse duration. In terms
of heating, this implies that for a given MR system, flip
angle and peripheral location of conductive wires are
"expensive" parameters. The target tissue also influences
heat dissipation: flowing blood dissipates heat more than,
for example, vascular occlusions.
Yeung and McVeigh [55] provide other important recom-
mendations on techniques to limit heating of conductive
devices. They assert that heating depends heavily on geo-
metric parameters such as insertion length and depth of
the catheter inside the body and with respect to the mag-
net isocenter and bore centerline. Very short and very long
wires are desirable; very short and very long insertion
lengths are undesirable. Eccentric wire position is undesir-
able as well.
Conductive transmission lines, for example using loop-
less (dipole-antenna) guidewires, have been considered
more challenging for higher field MR. Paul Bottomley's
lab recently reported loopless devices with decoupling
and detuning circuitry at 3 T [64]. Despite long
guidewires, both SNR and local sensitivity increased
quadratically; as anticipated by Yeung and McVeigh, heat-
ing did not.
Other groups have replaced conductive transmission lines
with fiberoptic cables, in one iteration using laser input to
detune resonant circuits (creating controlled local dephas-
ing "black spots") [65] rather than transmission of locally
detected MR signals. Fandry and colleagues in Hamburg
reported a fiberoptic transmission system that powers an
active intravascular device[66]. It reduces SNR compared
with electrical transmission lines but affords positive con-
trast and is an important advance. Michael Bock's group
described an innovative optical gradient sensor that
exploits the Faraday effect for catheter tracking, and uses
an optical transmission line [67].
Inductively-coupled devices
Inductive tuning and coupling of catheter devices avoids
heating of transmission lines and freedom from tethering
altogether. Inductively-coupled intravascular devices
amplify the local flip angle and the signal from adjacent
tissues. These have been prototyped as intravascular stents
which serve as the antenna [68,69]. Such devices can
enhance internal signal, such as neointima or flow inside
a stent or thrombus inside a cava filter. Unfortunately,
bulky electronics may interfere with stent biocompatibil-
ity and performance. Inductive coupling has been used to
implement safe "wireless" guiding catheters since the wire
loops are short [70]. Practically, inductively-coupled
devices require low flip angle imaging, which comes at the
expense of surrounding tissue context, and may also
require special miniaturized circuit elements to prevent
heating.
Without a transmission line, signal enhancement from
inductively-coupled devices usually cannot be distin-
guished (for example, displayed in different colors) from
signal enhancement from other surface coils. Duerk's
group [71] used optical-detuning of inductively-coupled
A comparison of passive (A) and active (B) catheter visualiza- tion techniques during rtMRI stent angioplasty in a porcine  model of aortic coarctation Figure 4
A comparison of passive (A) and active (B) catheter 
visualization techniques during rtMRI stent angi-
oplasty in a porcine model of aortic coarctation. Panel 
A uses a passive PTFE-coated 0.035" nitinol guidewire, while 
panel B uses a loopless active 0.030" guidewire. The plati-
num-iridium (Cheatham-Platinum, Numed, Inc) stent is 
crimped on a dilute gadolinium-filled balloon (white arrows). 
The devices are more conspicuous and the procedures more 
straightforward using the active guidewire technique [51].
B AJournal of Cardiovascular Magnetic Resonance 2008, 10:62 http://www.jcmr-online.com/content/10/1/62
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microcoils that were mounted on a catheter containing a
fiberoptic transmission line. The resonant microcoils
could be made to blink to aid in their localization and
tracking. The Philips Hamburg group [72] implemented
similar devices and methods to discriminate their signal
from surrounding tissue. Atalar's group [73] recently
described a method to detect "reverse polarized" local sig-
nal from inductively-coupled coils, and to distinguish it
from surrounding anatomic signals. This innovation
promises to provide safety advantages of passive devices,
some of the conspicuity of active devices, and avoids the
flip angle limitation of inductively-coupled coils (Figure
5).
Magnetic deflection and remote control
Magnetic deflection of catheter devices is commercially
deployed outside of MR to aid in catheter steering and
positioning. A University of Toronto team has reported
electromagnet-deflectable catheters for interventional MR
[74]. Martel and colleagues [75] have developed techni-
cally impressive integrated systems to navigate untethered
devices within blood vessels during MR using customized
gradient pulses. However, therapeutic devices using such
"untethered" designs remain to be demonstrated.
Multispectral and other catheter designs
Another noteworthy approach is passive tracking of non-
proton magnetic resonance species, which can therefore
be distinguished from proton MR of surrounding tissue.
The Kings College London team has reported tracking of
catheters filled with 19-Fluorine [76]. The Amersham
team uses catheters infused with hyperpolarized 13-Car-
bon [77] which also can be injected for selective angiogra-
phy with high SNR [78]. These solutions combine the
safety and simplicity of passive designs with the specificity
of active designs to distinguish catheter components from
target tissues.
One novel catheter zeugmatograph bears mention. The
Topspin catheter is a self-contained catheter MR system
that provides local intravascular diffusion-weighted meas-
urements of coronary artery segments [79,80]. The system
does not require a conventional MR system but does
require intravascular balloon inflation to appose it to the
artery wall because of its narrow field of view.
Applications
Applications suitable and not suitable for iCMR, including 
coronary intervention
Because MR affords flexible contrast and views at the
expense of reduced temporal resolution or signal-noise,
certain procedures are well suited for ICMR. These include
tissues that are large or thick-walled relative to attainable
fields of view (such as heart and aorta), tissue targets
imaged with high contrast compared with surrounding
tissue (such as myocardium against blood), and targets
that are relatively immobile (such as peripheral arteries).
Structures that can be contained within a single imaging
plane (such as straight segments of iliac arteries) can be
imaged rapidly, compared with small tortuous structures
such as coronary arteries, which are difficult to image in
real-time. Ventricular myocardium is especially attractive
in spite of cardiac and respiratory motion because it is
large, thick-walled, and well depicted with high contrast
using SSFP compared with cavitary blood. Conversely,
thin-walled cardiac atria are difficult to image even using
segmented MR.
Speuntrup et al [81] delivered passively-visualized stain-
less steel stents in coronary arteries of normal swine. The
devices and target proximal coronary arteries were imaged
superbly using SSFP at 1.5 T despite cardiac motion and
small targets. Unfortunately, barring significant technical
breakthroughs, meaningful human coronary interven-
tional procedures are unlikely to be performed under
iCMR guidance. X-ray fluoroscopy offers high temporal
(33–66 ms) and spatial (200–500 μm) resolution, allow-
ing operators to navigate sophisticated 0.35 mm (0.014")
diameter guidewires through small, heterogeneous, tortu-
ous, calicified, and even occluded coronary arteries.
Simple angioplasty and stenting procedures
Simple peripheral angioplasty is conducted effectively
under X-ray guidance, so iCMR guidance is not compel-
ling as a standalone application. Widely available, iCMR
might be an attractive radiation-free alternative that also
adds the ability to image uncommon complications such
as peri-vascular hemorrhage.
MR has been used to conduct transluminal angioplasty
[31,82-85] and stenting [51,69,86-92] in animal models
of iliac, renal, and carotid arteries.
A promising technique (reverse polarization) to impart "sig- natures" to inductively-coupled intravascular devices Figure 5
A promising technique (reverse polarization) to 
impart "signatures" to inductively-coupled intravas-
cular devices. This is tested in a phantom using phased-
array surface coils and real-time MRI. (A) Forward polarized 
mode shows the catheter and background. (B) Reverse 
polarization method distinguishes the inductively coupled 
receiver from background. The signal can be colorized and 
overlaid (C) as if it were an active catheter using a separate 
receiver chain. Courtesy Ergin Atalar, Bilkent University.
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The team at the University of Regensberg has performed
MR guided angioplasty and stenting in humans, using
only passive devices, of iliac [93] and of femoropopliteal
[94] atherosclerotic lesions.
Aortic coarctation, aneurysm, and dissection
The aorta is the largest artery, and proximal aortic inter-
ventions are complex under any circumstances. X-ray
alone is imperfect in visualizing complex three-dimen-
sional aneurysms. Endovascular repair for aortic aneu-
rysm is limited in part by endoleak due to inflow or
outflow malapposition. Raman and colleagues [95] used
MR to guide simple endograft tube repair of abdominal
aortic aneurysm in pig models. Homemade temporarily-
active endograft devices, which were depicted with color-
highlighting until they were disconnected as RF coils after
deployment, were more straightforward to use and more
successful than comparable passive endograft devices.
Endograft treatment under MR restored a normal lumen
contour and laminar flow. Moreover, MR demonstrated
device apposition to the target aortic wall and allowed
interrogation for endoleak.
Eggebrecht and colleagues in Essen, Germany, elegantly
applied iCMR to guide the placement of stent grafts in an
animal model of thoracic aortic dissection [96]. They used
off-the-shelf passive clinical self-expanding Gore TAG
endografts without a guidewire. MR clearly revealed the
true and false lumens of the dissected aorta, guided stent-
graft deployment, and demonstrated stent-graft oblitera-
tion of the dissection and false lumen. This was an excel-
lent demonstration of the value of simultaneous tissue
and device imaging to guide a complex procedure (Figure
6).
Our team used active guidewires to treat an animal model
of aortic coarctation with platinum-iridium stents [51].
Passive balloons filled with dilute gadolinium appeared
bright over this active guidewire, and MR was helpful in
displaying both target tissue and stent system during
deployment. Velocity-encoded MR confirmed the hemo-
dynamic results of the procedure. More important, MR
provided immediate evidence of life-threatening rupture
after intentional overstretch of the coarctation. In patients
this recognition would provide precious additional time
for rescue. Of note, the same procedure was far less effec-
tive when conducted using passive instead of active
guidewires (Figure 4). Other teams [97-99] have modeled
passive aortic endograft deployment in vitro or in vivo.
Krueger, Kuehne, and colleagues in Berlin performed bal-
loon angioplasty of aortic coarctation lesions in patients
during MR. This was an important first clinical step
toward wholly MR-guided treatment of this congenital
lesion [22] (Figure 7).
Chronic total occlusion
Perhaps more compelling are applications that exploit the
ability of MR to visualize vascular spaces not conspicuous
using X-ray. X-Ray with radiocontrast identifies the arter-
ies up- and down-stream of the occlusion, but the
occluded segment itself has no lumen to fill with radio-
contrast and therefore remains invisible to the operator.
"Blind" device manipulation risks procedural failure and
arterial perforation. MR can visualize both patent and
occluded artery segments, as well as the wall, lumen con-
tent, and adjacent structures, so it is attractive to guide
recanalization [100].
Raval and colleagues created an animal model of periph-
eral artery chronic total occlusion in swine. They recanal-
ized these lesions using homemade active devices under
MR, even though they were fairly unsuccessful using X-ray
and high-performance clinical guidewires [101]. MR
helped operators traverse complex occlusions while keep-
ing equipment inside the walls of the target artery. This is
especially important in recanalization of tortuous periph-
eral artery occlusions, such as the iliac arteries.
Clinical-grade devices are currently under development to
translate this experience into humans [102]. The group in
Sunnybrook Hospital has developed a novel forward-
looking catheter coil to guide recanalization using orthog-
onal solenoids.
Valve Interventions and MR-Guided Cardiac Surgery
Non-surgical replacement of heart valves has become fea-
sible, despite challenges in miniaturization, access, and
image-guided positioning. MR might aid in positioning
Real time MRI guided endograft treatment of aortic dissec- tion in swine Figure 6
Real time MRI guided endograft treatment of aortic 
dissection in swine. The dissection flap (arrowheads) sepa-
rates true lumen (TL) and false lumen (FL). (A & B) The pas-
sive endograft (arrows) has entered the false lumen and 
thereafter is redirected. Following endograft deployment, the 
false lumen is obliterated (Panel C). Courtesy Holger Egge-
brecht, University Essen [96].
C
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relative to vital structures such as coronary artery ostia.
Kuehne and colleagues [103] have reported preliminary
experience deploying a passively-visualized nitinol-based
aortic valve prosthesis from a transfemoral approach in
healthy swine. Their work demonstrates the value of com-
bined device and tissue imaging for precise placement of
critical prostheses. Such work may have value in complex
pulmonary valve implants in patients with prior surgery
for congenital heart disease.
Horvath, Guttman, and McVeigh at NIH have pursued
operative MR guidance for cardiac surgery [104]. Using a
minimally invasive incision to access the apex of the beat-
ing left ventricle, they have implanted commercial bio-
prosthetic heart valves mounted on stent devices into the
aortic valve position. MR aided in axial and rotational
positioning of the valve prosthesis with relation to the
aortic annulus and coronary artery ostia. The same team is
enhancing an MR-compatible robot for surgical applica-
tions [105]. MR-trackable thoracoscopes have been
described to combine MR-derived anatomic "context"
with optical imaging and direct instrument access [106].
Congenital and structural heart disease
Diagnostic catheterization in patients with congenital
heart disease is more complex and challenging than in
adults with acquired heart disease, and may not be guided
by ordinary anatomic predictions. Hearts after multiple
palliative interventions have additional morphological
complexity.
Clinical demonstration of iCMR guided therapy of aortic coarctation Figure 7
Clinical demonstration of iCMR guided therapy of aortic coarctation. (A) The large arrow points to the coarctation 
lesion. (B) A balloon dilatation catheter (double arrows) is positioned across the narrowing. (C and D) The balloon is inflated 
with a T2*-shortening agent. Panels E (aortic diameter) and F (pressure gradient) show favorable results of iCMR guided bal-
loon angioplasty in 4 out of 5 patients (pre/post indicates measured before/after intervention). Courtesy Titus Kuehne, Charité 
Hospital [22].
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Schalla and colleagues at University of California San
Francisco simulated clinical-grade pediatric diagnostic
catheterization in an animal model of atrial septal defect,
using active-tracking catheter devices. They combined
invasive hemodynamic measurements with velocity-
encoded MR [107]. Others have reported less complex
procedures in animals [108,109].
The pioneering clinical diagnostic MR catheterization at
Kings College London remains the landmark in the field
[110]. Since this first report, they have conducted hun-
dreds of diagnostic catheterization procedures in children
using passive devices and CO2-filled balloons in a com-
bined X-ray and MR suite (Figure 3d). In addition, they
routinely conduct interventional procedures overlaying
MR-derived roadmaps with live X-ray (see X-ray Fused
with MR or XFM, below). Patients undergoing MR-
assisted catheterization suffered significantly less radia-
tion exposure than those undergoing conventional X-ray
procedures.
The Kings College team [111,112] as well as Kuehne and
colleagues [113] at Berlin Charité Hospital have used MR
catheterization to make critical vessel-specific determina-
tions of pulmonary vascular flow and resistance in
patients with congenital heart disease or pulmonary artery
disease. These may overcome inherent limitations of oxi-
metry-derived measurements.
At least three teams have described iCMR guided deploy-
ment of nitinol occluder devices in animal atrial septal
defects [114-116]. This application may not be superior to
conventional or newer ultrasound guidance. Ventricular
septal defect suffers additional morphological and proce-
dural complexity that may benefit from iCMR.
Connecting Chambers and Vessels
An especially attractive application of iCMR is the inten-
tional violation of ordinary tissue spaces. A simple step in
this direction is to connect adjacent vascular structures
during atrial septal puncture. Arepally and colleagues at
Johns Hopkins University [117] first described MR guided
puncture of the interatrial septum using an active Brock-
enbrough-style needle. Our lab [45] conducted similar
transseptal puncture and balloon septostomy, with MR
assessment of the intracardiac shunts created. MR has par-
ticular value in specific identification and location of the
"dangerous" tip compared with two-dimensional ultra-
sound. We did similar atrial septal puncture using an abla-
tive laser catheter with an active-imaging distal tip coil
[118], which by virtue of its flexibility could be applied in
the future to more challenging geometry and more elabo-
rate procedures.
Arepally and colleagues also used a similar active needle
to effect a transcatheter mesocaval shunt, connecting the
vena cava and the superior mesenteric vein using a nitinol
connector [117]. They have also used this approach to
deliver iron-labeled pancreatic beta-cell microcapsules
under MR guidance to treat a model of islet-cell deficiency
diabetes mellitus [119].
Using a unique double-doughnut MR configuration con-
taining an integrated flat-panel X-Ray fluoroscopy system,
Kee and colleagues at Stanford conducted preclinical
[120] and clinical [121] transjugular intrahepatic porto-
systemic shunt (TIPS) procedures, which connect the
hepatic and portal venous circulations in portal hyperten-
sion syndromes. MR guidance reduced the number of
unsuccessful punctures, which can be hazardous.
Used this way, iCMR might enable non-surgical connec-
tions between other non-adjacent vascular structures, for
example connecting the subclavian and pulmonary arter-
ies, or the aorta and femoral arteries. Catheter-based extra-
anatomic bypass might be an attractive alternative to
open-surgical bypass, and is under active development.
MR should permit inspection of vascular and extravascu-
lar spaces, the trajectory of connecting devices, and instan-
taneous assessment of the adequacy of catheter-based
anastomoses.
Cell and drug delivery to the myocardium
Several labs [25,122-129] have used iCMR and active or
passive catheters to deliver cells and other materials into
specified targets in normal and infarcted animal hearts. As
described above, thick myocardial walls and high contrast
with blood during SSFP MR afford excellent image guid-
ance, and targeting based on multiple factors including
late gadolinium enhancement, wall motion abnormali-
ties, thickness, or anatomic position. Labeling or admix-
ing injectate with contrast agents helps to confirm
successful delivery, to assess intramyocardial redistribu-
tion, to assure confluent treatment volumes, or to avoid
inadvertent injection overlap. The long-term value of
exogenous intracellular contrast for tracking cell fate is at
best controversial [130,131]. Promising therapeutic cell
preparations have not yet been identified at the time of
this writing. Should precise targeting be valuable for a
future cell preparation, iCMR could be a valuable delivery
tool.
Image-guided Electrophysiology Procedures
In this family of procedures, cardiac rhythm pathways are
mapped and interrupted by focused energy delivery or
surgery. In catheter approaches, plans or even maps are
routinely constructed using intracardiac electrograms
and/or adjunctive X-ray, ultrasound, or imported tomo-
graphs. Multipolar pacing and ablation catheters are then
guided by combinations of these images and maps and
even can be directed by external magnetic deflection.
Ablation lesions are interactively assessed by local heatingJournal of Cardiovascular Magnetic Resonance 2008, 10:62 http://www.jcmr-online.com/content/10/1/62
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and the impact on local and regional electrograms and
rhythms, but not generally by imaging. In a surgical
approach, anatomic myocardial segments are insulated
from others under direct visualization. iCMR might afford
surgical-style anatomic imaging guidance to catheter pro-
cedures, in positioning and in depicting actual ablation
lesions during procedures [132].
MR with or without late gadolinium enhancement might
have clinical value in identifying early tissue response to
radiofrequency ablations [133-135], ablation lesions and
perhaps lines of continuity as an imaging correlate of
functional electrophysiologic block in thin walled atrial
tissue [132,136,137], and the complex substrate of ven-
tricular tachycardia [138]. MR already is in widespread
clinical use overlaid with live X-ray or electroanatomical
maps [139-142].
Henry Halperin's team at Johns Hopkins University first
described active-imaging MR catheters with appropriate
filtering to acquire intracardiac electrograms during real-
time MR [143]. In a recent landmark study, they obtained
first-in-man intracardiac electrograms in patients during
MR [144] (Figure 8).
Vivek Reddy and colleagues at Massachusetts General
Hospital in collaboration with General Electric [36] devel-
oped and tested novel real-time MR tracking of electro-
physiology catheters in animals overlaid on high-
resolution time-resolved MR images of myocardium
obtained in the same system (Figure 9).
Transarterial embolic protection, embolotherapy, and 
angiography
iCMR has been used to deploy prophylactic inferior vena
cava filters in order to arrest ascending thromboembolism
[145-148] and to visualize captured embolic material.
MR also has been used to guide visceral artery emboliza-
tion, such as kidney segments, and affected parenchyma
[149,150]. The Northwestern University team has coated
polyvinyl alcohol particles with gadolinium chelates to
monitor transcatheter arterial embolization procedures
[151].
MR may have incremental value in tissue monitoring and
assessment during and after interventional procedures,
affecting for example renal [152] and myocardial paren-
chyma [153].
Clinically, Omary and colleagues at Northwestern Univer-
sity have been active in conducting clinical embolother-
apy procedures in a combined X-ray and MR suite. MR
perfusion assessment helped guide uterine artery emboli-
zation for leiomyoma (fibroids) [154]. Similarly they
have used MR to monitor hepatic chemoembolization
procedures for malignancy [155].
Bozlar and colleagues at University of Virginia [156]
reported an innovative application of selective intraarte-
rial contrast enhanced MR angiography. They subtracted
intraarterial gadolinium MR contrast images from sys-
temic (intravenous) contrast images to identify feeding
collateral arteries in a pelvic arteriovenous malformation.
Solely diagnostic applications of selective intraarterial
contrast enhanced MR angiography [157] are less compel-
ling than those combined with therapeutic procedures
[16].
Multi-modal image fusion: instant gratification
Multi-modal imaging systems are intended to provide
some of the best features of both X-ray (simplicity and
broad array of clinical catheter devices) and MR (soft-tis-
sue landmarks).
Hybrid X-ray MR Systems
Fahrig and colleagues at Stanford University developed a
hybrid X-ray and MR system based on a double-donut MR
scanner, with an X-ray source and detector mounted
inside the magnet bore [158,159]. Images can be acquired
alternately from X-ray and MR without moving the
patient, providing images that are automatically co-regis-
tered. Several innovations have come out of the develop-
ment of this system, such as X-ray transparent aluminum
MR coils [160]. This system has been used clinically for
Intracardiac electrograms are obtained during rtMRI in dogs  without (left) and with (right) filtering using an MRI-compati- ble cardiac electrophysiology system Figure 8
Intracardiac electrograms are obtained during rtMRI 
in dogs without (left) and with (right) filtering using 
an MRI-compatible cardiac electrophysiology system. 
The same system was used in two human patients. Courtesy 
of Henry R. Halperin, MD, Johns Hopkins University [144].Journal of Cardiovascular Magnetic Resonance 2008, 10:62 http://www.jcmr-online.com/content/10/1/62
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transjugular intrahepatic portosystemic shunt (TIPS) crea-
tion [121] as described above. In addition, a system based
on a 1.5 T closed bore system, with the X-ray gantry
mounted just outside the magnet has been proposed
[161].
X-ray Fused with MR
MR roadmaps can be combined with live X-ray fluoros-
copy using a conventional clinical environment and con-
ventional catheter equipment, to provide additional
anatomic landmarks and functional information to guide
procedures [162,163].
In addition to the registration of the MR and X-ray coordi-
nate systems, the X-ray system must be calibrated to com-
pensate for image distortions. These orientation-
dependent distortions are caused by C-arm imperfections
(e.g. pincushion distortions, gantry fatigue) and the influ-
ence of the MR system's main magnetic field on the X-ray
image intensifier. Using two-dimensional and three-
dimensional phantoms with fiducial markers at known
locations, warping polynomials may be calculated which
can be used for distortion correction [164,165]. These dis-
tortions are less important using contemporary flat-panel
X-ray detectors.
Active-tracking microcoils are positioned in an MRI system using a prior time-resolved three-dimensional cardiac MR image Figure 9
Active-tracking microcoils are positioned in an MRI system using a prior time-resolved three-dimensional car-
diac MR image. Left atrium (around pulmonary veins) in a pig is evaluated using MRI compatible electrophysiology catheter 
and sheath system (Panels A & B). Ablation sites are mapped in an interactive three-dimensional display (Panel C) and seen on 
necropsy (Panel D). Courtesy of Ehud Schmidt, PhD, General Electric [36].
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In order to merge MR and X-ray images, the coordinate
systems of each must be aligned. The approach taken by
Razavi is to use a calibration phantom, which can accom-
modate X-ray or MR compatible markers, to compute the
transformation between MR scanner space and X-ray table
space. The position of the X-ray components are tracked
using infrared emitting diodes placed on the X-ray C-arm
and table. An additional marker may be placed on the
patient's chest to allow for adjustments to the registration
to be made in case of gross patient motion [140,162].
In our lab, registration is accomplished by placing multi-
modality external fiducial markers either directly on the
patient's skin or in an elastic band around the patient's
torso. The markers contain a mixture of iodinated X-ray
contrast and gadolinium based MR contrast, so that they
can easily be identified in both imaging modalities. A
three-dimensional MR T1-weighted acquisition and a set
of multiple baseline X-ray projections are used to register
the two coordinate systems. Using custom built software,
the three-dimensional positions of the markers are auto-
matically reconstructed from the MR and X-ray images,
correspondence between the markers is established, and a
three-dimensional rigid registration algorithm is used to
align the MR coordinate system with the X-ray coordinate
system.
Relevant anatomic landmarks (e.g. myocardial surfaces,
the great vessels, cardiac valves) and treatment sites (e.g.
ventricular septal defect, myocardial infarct, injection tar-
get) are segmented on MR images and can be color-coded.
Two-dimensional projections of these three-dimensional
contours are constructed based on the X-ray gantry orien-
tation, registration calculations, and calibration data.
These projections are overlaid on the X-ray fluoroscopy
images and displayed in the angiography suite (Figure
10). Position information from the X-ray system (c-arm
angle, table position, magnification factor) is used auto-
matically to adjust the displayed MR derived contours
with the fluoroscopic images during a procedure.
The Kings College London team uses X-ray Fused with MR
(XFM) to provide soft tissue context to clinical electro-
physiology procedures [162] and pediatric interventional
procedures. Our lab has used XFM to guide cell delivery to
infarct targets with millimeter precision, using targets
such as infarct borders or zones of excessive thinning
[166]. We also have used XFM to guide a novel antegrade
approach to catheter-based repair of membranous ven-
tricular defect in swine (Figure 10), which significantly
shortened X-ray exposure compared with the conven-
tional retrograde approach [167], as well as a novel
approach to catheter-based mitral annuloplasty involving
an intramyocardial guidewire trajectory. In patients we
have used XFM to facilitate biopsy of high risk cardiac
structures, and to aid in recanalization of chronic total
peripheral artery occlusion [163].
A significant limitation of the XFM type roadmap
approaches is that out-of-date roadmap information can
be misleading or hazardous. Roadmap information can
be distorted by rigid devices, by changes in the underlying
tissue structure related to the intervention, and from
uncorrected cardiac and respiratory motion.
Conclusion
We have outlined how and why to configure an interven-
tional CMR facility. The incremental cost of an intermo-
dality transportation system and of barrier doors is
relatively low. Existing technology already provides excel-
lent real-time MR imaging sufficient to guide investiga-
tional therapeutic procedures, and to care for patients in
this environment. Clinical grade catheter devices remain
the last persistent obstacle to widespread investigational
use of iCMR.
Important competing technology is available. Electromag-
netic position mapping relies on prior (roadmap) ana-
tomic information. CT provides superb soft-tissue
imaging but even newer massive detector arrays expose
patients to prohibitive doses of ionizing radiation to
guide interventional cardiovascular procedures. C-arm
based cone-beam CT techniques create effective soft-tissue
roadmaps, but radiation exposure limits the ability to
inspect the impact of procedures. Three-dimensional sur-
face and transesophageal ultrasound provides some of the
functionality promised by MR with little fuss, albeit with
inferior acoustic windows.
MR may prove superior because it provides single-station
imaging, combining three-dimensional anatomy, bio-
chemical characterization, mechanical function, and
hemodynamics. Real-time MR provides "surgical" expo-
sure that can revolutionize minimally invasive proce-
dures. The mythological figure Tantalus was punished
with temptation by fruits and drink eternally out of reach.
Readers of reviews like this have long been tempted by
fruits of MR-guided intervention. Seemingly eternally tan-
talizing, clinical interventional CMR is nearing our grasp.
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X-ray Fused with MRI (XFM) guided repair of a membranous ventricular septal defect in swine [167] Figure 10
X-ray Fused with MRI (XFM) guided repair of a membranous ventricular septal defect in swine [167]. Panel A 
shows traditional X-ray contrast left ventriculogram highlighting ventricular septal defect (VSD; thick, white arrow). Panel B 
shows turbo spin-echo 3 chamber view, which highlights the VSD (thick, white arrow) in the same orientation as X-ray image 
in panel A. MRI regions of interest were segmented manually to be presented to the operator as a static image overlay on real-
time X-ray fluoroscopic images. Panel C is a schematic depicting a new XFM guided antegrade approach to crossing the VSD in 
order to close the defect with a nitinol implant. XFM roadmap (Panel D) elements include the right ventricular endocardial 
contour (yellow), the left ventricular epicardial contour (green), the left ventricular endocardial contour (blue), the VSD tract 
(red outline and black arrow), aortic root (red), and aortic valve (blue annulus with white leaflets). The guidewire (white 
arrowhead) is delivered across the VSD and into the aorta.
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